June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Gilead Sciences (GILD) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 22, 2025 (19:39)
Sector: HealthcareThe share price of Gilead Sciences, Inc. (GILD) now
Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2025, 2026, 2027. How much will one Gilead Sciences share be worth in 2025 - 2027?
When should I take profit in Gilead Sciences stock? When should I record a loss on Gilead Sciences stock? What are analysts' forecasts for Gilead Sciences stock? What is the future of Gilead Sciences stock? We forecast Gilead Sciences stock performance using neural networks based on historical data on Gilead Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Gilead Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Gilead Sciences shares. This happens once a day.
Historical and forecast chart of Gilead Sciences stock
The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Gilead Sciences stock price can be found in the table below.
Long-term forecasts by years.
Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.
Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.
Gilead Sciences daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 24 | 109.23 | 108.70 | 109.75 | 0.96 |
| Jun 25 | 108.82 | 108.16 | 109.17 | 0.94 |
| Jun 26 | 108.49 | 107.87 | 108.83 | 0.89 |
| Jun 27 | 107.46 | 107.17 | 107.71 | 0.51 |
| Jun 28 | 107.13 | 106.68 | 107.53 | 0.79 |
| Jun 29 | 107.66 | 107.43 | 108.43 | 0.93 |
| Jun 30 | 107.57 | 106.99 | 108.30 | 1.23 |
| Jul 01 | 107.19 | 106.40 | 107.91 | 1.42 |
| Jul 02 | 107.85 | 107.38 | 108.44 | 0.99 |
| Jul 03 | 107.73 | 107.12 | 108.42 | 1.22 |
| Jul 04 | 107.63 | 107.26 | 108.05 | 0.74 |
| Jul 05 | 107.75 | 107.27 | 108.49 | 1.14 |
| Jul 06 | 108.39 | 108.16 | 108.89 | 0.67 |
| Jul 07 | 108.32 | 107.99 | 109.09 | 1.02 |
| Jul 08 | 108.43 | 108.21 | 109.06 | 0.78 |
| Jul 09 | 108.03 | 107.51 | 108.78 | 1.18 |
| Jul 10 | 108.80 | 108.38 | 109.15 | 0.70 |
| Jul 11 | 108.25 | 107.93 | 109.11 | 1.09 |
| Jul 12 | 108.30 | 107.78 | 108.72 | 0.87 |
| Jul 13 | 108.16 | 107.91 | 108.48 | 0.53 |
| Jul 14 | 107.70 | 106.99 | 108.45 | 1.36 |
| Jul 15 | 107.80 | 107.52 | 108.35 | 0.77 |
| Jul 16 | 107.78 | 107.13 | 108.10 | 0.91 |
| Jul 17 | 108.76 | 108.29 | 109.31 | 0.94 |
| Jul 18 | 108.37 | 107.50 | 109.22 | 1.60 |
| Jul 19 | 108.79 | 108.16 | 109.10 | 0.87 |
| Jul 20 | 109.30 | 108.94 | 109.92 | 0.90 |
| Jul 21 | 109.27 | 108.75 | 109.58 | 0.76 |
| Jul 22 | 108.51 | 107.72 | 109.28 | 1.45 |
| Jul 23 | 108.46 | 107.72 | 109.31 | 1.47 |
Gilead Sciences Daily Price Targets
Gilead Sciences Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $109.23.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.955%.
Pessimistic target level: 108.70
Optimistic target level: 109.75
Gilead Sciences Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $108.82.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.927%.
Pessimistic target level: 108.16
Optimistic target level: 109.17
Gilead Sciences Stock Forecast 06-26-2025.
Forecast target price for 06-26-2025: $108.49.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.887%.
Pessimistic target level: 107.87
Optimistic target level: 108.83
Gilead Sciences Stock Forecast 06-27-2025.
Forecast target price for 06-27-2025: $107.46.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.509%.
Pessimistic target level: 107.17
Optimistic target level: 107.71
Gilead Sciences Stock Forecast 06-28-2025.
Forecast target price for 06-28-2025: $107.13.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.788%.
Pessimistic target level: 106.68
Optimistic target level: 107.53
Gilead Sciences Stock Forecast 06-29-2025.
Forecast target price for 06-29-2025: $107.66.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.923%.
Pessimistic target level: 107.43
Optimistic target level: 108.43
GILD (GILD) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 112.56 | 109.97 | 115.48 | 4.78 |
| Jul. | 113.85 | 109.92 | 117.78 | 6.67 |
| Aug. | 115.05 | 112.29 | 116.66 | 3.75 |
| Oct. | 110.33 | 108.62 | 114.58 | 5.20 |
| Oct. | 112.70 | 109.10 | 115.75 | 5.75 |
| Dec. | 110.73 | 106.74 | 113.50 | 5.95 |
| Dec. | 114.94 | 111.37 | 118.79 | 6.24 |
Gilead Sciences forecast for this year
Gilead Sciences Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $112.557. Pessimistic: $109.97. Optimistic: $115.48
Gilead Sciences Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $113.851. Pessimistic: $109.92. Optimistic: $117.78
Gilead Sciences Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $115.047. Pessimistic: $112.29. Optimistic: $116.66
Gilead Sciences Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $110.33. Pessimistic: $108.62. Optimistic: $114.58
Gilead Sciences Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $112.702. Pessimistic: $109.10. Optimistic: $115.75
Gilead Sciences Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $110.73. Pessimistic: $106.74. Optimistic: $113.50
Gilead Sciences Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $114.937. Pessimistic: $111.37. Optimistic: $118.79
Gilead Sciences (GILD) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 116.95 | 114.32 | 120.28 | 4.96 |
| Mar | 117.18 | 114.72 | 119.23 | 3.78 |
| Mar | 122.16 | 118.74 | 124.06 | 4.28 |
| May | 122.53 | 118.79 | 125.16 | 5.09 |
| May | 120.32 | 118.88 | 124.84 | 4.77 |
| Jul | 121.65 | 120.43 | 125.78 | 4.25 |
| Jul | 127.30 | 123.99 | 129.79 | 4.46 |
| Aug | 129.66 | 125.51 | 131.41 | 4.49 |
| Oct | 134.46 | 130.96 | 139.03 | 5.80 |
| Oct | 134.59 | 133.18 | 138.49 | 3.84 |
| Dec | 131.56 | 127.95 | 133.67 | 4.28 |
| Dec | 130.05 | 125.50 | 133.50 | 5.99 |
Gilead Sciences (GILD) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 129.59 | 124.80 | 133.74 | 6.69 |
| Mar | 125.45 | 122.56 | 129.09 | 5.05 |
| Mar | 128.58 | 125.50 | 133.21 | 5.79 |
| May | 127.68 | 124.68 | 130.30 | 4.31 |
| May | 133.37 | 131.23 | 137.90 | 4.84 |
| Jul | 137.43 | 132.90 | 140.25 | 5.24 |
| Jul | 141.69 | 137.87 | 144.03 | 4.28 |
| Aug | 141.27 | 137.10 | 144.80 | 5.32 |
| Oct | 143.74 | 139.86 | 148.48 | 5.81 |
| Oct | 142.66 | 137.81 | 146.59 | 5.99 |
| Dec | 142.38 | 137.47 | 144.16 | 4.64 |
| Dec | 144.73 | 140.60 | 147.48 | 4.66 |
Gilead Sciences information and performance
333 LAKESIDE DR, FOSTER CITY, CA, US
Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.
EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Gilead Sciences (GILD) stock dividend
Gilead Sciences last paid dividends on 06/13/2025. The next scheduled payment will be on 06/27/2025. The amount of dividends is $3.1 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
FAQ (Frequently Asked Questions about Gilead Sciences Stock)
Should I Buy Gilead Sciences Shares in 2025 year?
Does Gilead Sciences pay dividends?
Which economic sector do Gilead Sciences's shares belong to?
Which other securities belong to the same sector as Gilead Sciences's shares?
Related stocks from Healthcare sector
